查看購物車
  • Simplified Chinese
  • English
  • Japanese
2021-2031 年亞太地區藥物警戒和藥物安全軟體市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1819688

2021-2031 年亞太地區藥物警戒和藥物安全軟體市場報告（範圍、細分、動態和競爭分析）

Asia Pacific Pharmacovigilance and Drug Safety Software Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 227 Pages | 訂單完成後即時交付

價格

2023 年亞太地區的藥物警戒和藥物安全軟體市場價值約為 4,440 萬美元，預計到 2031 年將成長到 6,866 萬美元。這一成長代表著 2023 年至 2031 年的年複合成長率(CAGR) 為 5.6%。

這項市場擴張的重要驅動力在於人工智慧 (AI)、機器學習 (ML) 和自然語言處理 (NLP) 等先進技術的融合。這些技術正在徹底改變藥物警戒相關的傳統資源密集流程，從而實現更明智、更有效率的營運。現代藥物警戒軟體平台日益配備了先進的分析和人工智慧功能，增強了對安全訊號的識別能力。透過分析大型資料集，這些工具可以發現傳統方法可能遺漏的關聯性和模式。此外，人工智慧驅動的預測分析可以預測潛在的安全問題，使企業能夠採取主動措施。

機器學習模型在預測與藥物使用相關的不良事件方面尤其有用。例如，藥物警戒計畫利用機器學習分析大量資料集，識別可能暗示藥物不良反應風險的模式。這些演算法擅長處理非結構化資料，例如社群媒體內容和病患記錄，從而有效預測安全隱患。

市場上一些關鍵參與者正在開發基於人工智慧的自動化監測工具，以促進製藥公司的藥物開發。值得注意的是，科睿唯安於2021年5月推出了DialogML，這是一個由人工智慧驅動的藥物警戒文獻監測軟體平台。此工具可自動監測藥物警戒文獻，簡化彙總報告產生和安全訊號審查等流程。 2024年1月，PubHive Ltd.推出了一個創新的集中式產品特性彙總（SmPC）管理平台，該平台整合了人工智慧驅動的藥物警戒工作流程。該平台專為生命科學、製藥公司和臨床研究組織（CRO）設計，旨在提高藥物警戒團隊的合規性和營運效率。

人工智慧系統在即時藥物安全監測中的應用日益普遍，該監測涵蓋臨床試驗資料、醫學文獻綜述和患者登記，以識別不良事件 (AE)。這種主動方法提高了藥物不良反應 (ADR) 檢測的準確性和速度。此外，自然語言處理 (NLP) 技術使人工智慧系統能夠從海量文字資料集中提取相關資訊，例如藥物名稱和症狀，從而促進快速準確的不良事件報告。此功能可加速識別新的或先前未知的藥物安全問題，顯著地推進藥物警戒工作。

亞太地區藥物警戒和藥物安全軟體市場涵蓋多個國家，包括印度、中國、日本、韓國、澳洲以及亞太地區其他地區。該地區的醫療保健和製藥業正經歷數位化浪潮。例如，印度政府啟動了多個項目，例如「阿育曼印度數位化使命」和「CoWIN」應用程式，旨在提高醫療保健的可及性。同樣，澳洲也致力於實現醫療保健和製藥業的現代化，並於2022年3月宣布了一項重大投資，金額高達7.491萬美元（10.72萬澳元）。

在製藥公司中，人工智慧與藥物警戒和藥物安全軟體的整合正變得越來越普遍，它們利用這些系統來監測、收集、分析和管理藥物安全資料。隨著亞太地區對藥物警戒的需求不斷成長，企業明顯傾向於採用先進的軟體解決方案。這些工具應用於藥物開發的各個階段，包括上市前、上市後監測、臨床試驗。因此，製藥業數位化措施的興起以及藥物警戒軟體的日益普及預計將推動亞太地區市場的成長。

市場進一步根據產品、部署方式、企業規模、軟體形式、功能和最終用戶進行分類。就產品而言，市場分為軟體和服務，其中軟體部分在2023年將佔據更大的佔有率。就部署而言，雲端部分也佔據了相當大的市場佔有率，反映出人們對基於雲端的解決方案的偏好。

從企業規模來看，大型企業佔據市場主導地位；從軟體形態來看，則分為標準軟體和客製化解決方案，其中標準軟體佔據主導地位。從功能來看，市場涵蓋訊號與風險管理、不良事件追蹤、個案管理、臨床安全管理等細分領域，其中訊號與風險管理最為突出。

就最終用戶而言，製藥和生物技術公司佔據最大的佔有率，而市場也按國家細分，中國在 2023 年的市場佔有率將領先。

亞太地區藥物警戒和藥物安全軟體市場的主要參與者包括 Veeva Systems Inc.、IQVIA Holdings Inc.、AB Cube SAS、ArisGlobal LLC、甲骨文公司、Max Application、ICON Plc、Cognizant Technology Solutions Corp、埃森哲公司、Syneos Health Inc.、Genpact Ltd.、Laboraizant Technology Solutions 總部、埃森哲公司、Syneos Health Inc.、Genpact Ltd.、Laboraizant Technology Solutions Holdings、A Technologiesal Solutions。這些公司在開發增強藥物安全和藥物警戒實踐的創新解決方案方面處於領先地位。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • 假設和局限性

第4章：亞太地區藥物警戒與藥品安全軟體市場格局

  • 概述
  • 生態系分析
  • 價值鏈中的供應商列表

第5章：亞太藥物警戒與藥品安全軟體市場－主要市場動態

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響：

第6章：亞太藥物警戒與藥品安全軟體市場 - 分析

  • 2021-2031年亞太地區藥物警戒與藥物安全軟體市場收入
  • 亞太藥物警戒與藥品安全軟體市場預測分析

第7章：亞太藥物警戒與藥品安全軟體市場分析 - 按產品

  • 軟體
  • 服務

第 8 章：亞太地區藥物警戒與藥品安全軟體市場分析 - 按部署

  • 雲
  • 本地

第9章：亞太地區藥物警戒與藥品安全軟體市場分析－依企業規模

  • 大型企業
  • 中小企業

第 10 章：亞太藥物警戒與藥品安全軟體市場分析 - 按形式

  • 標準
  • 客製化

第 11 章：亞太地區藥物警戒與藥品安全軟體市場分析 - 按功能

  • 訊號和風險管理
  • 問題追蹤和不良事件追蹤
  • 案件管理
  • 臨床安全管理與臨床試驗安全
  • 品質與合規
  • 醫學寫作
  • 審計支援和培訓合規性
  • 醫療保健分析
  • 其他

第 12 章：亞太藥物警戒與藥品安全軟體市場分析 - 按最終用戶

  • 製藥和生物技術公司
  • 合約研究組織
  • 業務流程外包（BPO）公司
  • 其他

第 13 章：亞太藥物警戒與藥品安全軟體市場 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區

第 14 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 15 章：產業格局

  • 概述
  • 市場計劃
  • 夥伴關係與合作

第 16 章：公司簡介

  • ArisGlobal LLC
  • Max Application
  • Oracle Corp
  • Veeva Systems Inc
  • IQVIA Holdings Inc
  • ICON Plc
  • Cognizant Technology Solutions Corp
  • Accenture Plc
  • Syneos Health Inc
  • Genpact Ltd.
  • AB Cube S.A.S.
  • Laboratory Corp of America Holdings
  • Parexel International Corp
  • Qinecsa Solutions
  • Clinevo Technologies

第 17 章：附錄

Product Code: TIPRE00022770

The pharmacovigilance and drug safety software market in the Asia Pacific region was valued at approximately US$ 44.40 million in 2023, with projections indicating it will grow to US$ 68.66 million by 2031. This growth represents a compound annual growth rate (CAGR) of 5.6% from 2023 to 2031.

A significant driver of this market expansion is the integration of advanced technologies such as artificial intelligence (AI), machine learning (ML), and natural language processing (NLP). These technologies are revolutionizing the traditionally resource-intensive processes associated with pharmacovigilance, leading to more informed and efficient operations. Modern pharmacovigilance software platforms are increasingly equipped with sophisticated analytics and AI capabilities that enhance the identification of safety signals. By analyzing large datasets, these tools can uncover correlations and patterns that might be missed by conventional methods. Furthermore, AI-driven predictive analytics can anticipate potential safety issues, enabling companies to implement proactive measures.

Machine learning models are particularly useful in predicting adverse events related to drug use. For example, pharmacovigilance initiatives utilize ML to analyze extensive datasets, identifying patterns that may suggest risks of adverse drug reactions. These algorithms excel at processing unstructured data, such as social media content and patient records, to forecast safety concerns effectively.

Several key players in the market are developing automated AI-based monitoring tools to facilitate drug development for pharmaceutical companies. Notably, in May 2021, Clarivate introduced DialogML, an AI-driven pharmacovigilance literature monitoring software platform. This tool automates the monitoring of pharmacovigilance literature, streamlining processes such as aggregate report generation and safety signal reviews. In January 2024, PubHive Ltd. launched an innovative centralized summary of product characteristics (SmPC) management platform that incorporates AI-powered pharmacovigilance workflows. This platform is designed for life sciences, pharmaceutical companies, and clinical research organizations (CROs), enhancing compliance and operational efficiency for pharmacovigilance teams.

The use of AI systems is increasingly prevalent in real-time drug safety monitoring, which encompasses clinical trial data, medical literature reviews, and patient registries to identify adverse events (AEs). This proactive approach improves the accuracy and speed of adverse drug reaction (ADR) detection. Additionally, NLP technologies enable AI systems to extract pertinent information, such as drug names and symptoms, from extensive textual datasets, facilitating rapid and accurate adverse event reporting. This capability accelerates the identification of new or previously unknown drug safety issues, significantly advancing pharmacovigilance efforts.

The Asia Pacific pharmacovigilance and drug safety software market is segmented into various countries, including India, China, Japan, South Korea, Australia, and the rest of the Asia Pacific region. The region is experiencing a surge in digitization within its healthcare and pharmaceutical sectors. For instance, the Indian government has initiated several programs, such as the Ayushman Bharat Digital Mission and the CoWIN App, aimed at enhancing healthcare accessibility. Similarly, Australia has committed to modernizing its healthcare and pharmaceutical sectors, with a notable investment of US$ 74.91 thousand (AU$ 107.2 thousand) announced in March 2022.

The integration of AI in pharmacovigilance and drug safety software is becoming increasingly common among pharmaceutical companies, which utilize these systems to monitor, collect, analyze, and manage drug safety data. As the demand for pharmacovigilance grows across the region, there is a marked shift towards adopting advanced software solutions. These tools are employed throughout various stages of drug development, including pre-marketing and post-marketing surveillance, as well as during clinical trials. Consequently, the rise in digitalization initiatives within the pharmaceutical sector and the increasing adoption of pharmacovigilance software are expected to drive market growth in the Asia Pacific region.

The market is further categorized based on offerings, deployment methods, enterprise size, software form, functionality, and end users. In terms of offerings, the market is divided into software and services, with the software segment holding a larger share in 2023. Regarding deployment, the cloud segment has also captured a significant market share, reflecting a preference for cloud-based solutions.

When considering enterprise size, large enterprises dominate the market, while the software form is categorized into standard and customized solutions, with standard software leading in market share. Functionality-wise, the market includes segments such as signal and risk management, adverse event tracking, case management, and clinical safety management, with signal and risk management being the most prominent segment.

In terms of end users, pharmaceutical and biotechnology companies represent the largest segment, while the market is also segmented by country, with China leading in market share in 2023.

Key players in the Asia Pacific pharmacovigilance and drug safety software market include Veeva Systems Inc., IQVIA Holdings Inc., AB Cube S.A.S., ArisGlobal LLC, Oracle Corp, Max Application, ICON Plc, Cognizant Technology Solutions Corp, Accenture Plc, Syneos Health Inc., Genpact Ltd., Laboratory Corp of America Holdings, Parexel International Corp, Qinecsa Solutions, and Clinevo Technologies. These companies are at the forefront of developing innovative solutions that enhance drug safety and pharmacovigilance practices.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:
  • 3.3 Assumptions and Limitations

4. Asia Pacific Pharmacovigilance and Drug Safety Software Market Landscape

  • 4.1 Overview
  • 4.2 Ecosystem Analysis
  • 4.3 Lit of Vendors in the Value Chain

5. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

  • 5.1 Market Drivers
  • 5.2 Market Restraints
  • 5.3 Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact of Drivers and Restraints:

6. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Analysis

  • 6.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Offering

  • 7.1 Software
    • 7.1.1 Overview
    • 7.1.2 Software: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 7.2 Services
    • 7.2.1 Overview
    • 7.2.2 Services: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Deployment

  • 8.1 Cloud
    • 8.1.1 Overview
    • 8.1.2 Cloud: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 8.2 On Premises
    • 8.2.1 Overview
    • 8.2.2 On Premises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Enterprise Size

  • 9.1 Large Enterprises
    • 9.1.1 Overview
    • 9.1.2 Large Enterprises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 9.2 SMEs
    • 9.2.1 Overview
    • 9.2.2 SMEs: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

10. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Form

  • 10.1 Standard
    • 10.1.1 Overview
    • 10.1.2 Standard: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 10.2 Customized
    • 10.2.1 Overview
    • 10.2.2 Customized: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

11. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Functionality

  • 11.1 Signal and Risk Management
    • 11.1.1 Overview
    • 11.1.2 Signal and Risk Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.2 Issue Tracking and Adverse Event Tracking
    • 11.2.1 Overview
    • 11.2.2 Issue Tracking and Adverse Event Tracking: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.3 Case Management
    • 11.3.1 Overview
    • 11.3.2 Case Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.4 Clinical Safety Management and Clinical Trial Safety
    • 11.4.1 Overview
    • 11.4.2 Clinical Safety Management and Clinical Trial Safety: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.5 Quality and Compliance
    • 11.5.1 Overview
    • 11.5.2 Quality and Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.6 Medical Writing
    • 11.6.1 Overview
    • 11.6.2 Medical Writing: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.7 Audit Support and Training Compliance
    • 11.7.1 Overview
    • 11.7.2 Audit Support and Training Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.8 Healthcare Analytics
    • 11.8.1 Overview
    • 11.8.2 Healthcare Analytics: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.9 Others
    • 11.9.1 Overview
    • 11.9.2 Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

12. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by End User

  • 12.1 Pharmaceutical and Biotechnology Companies
    • 12.1.1 Overview
    • 12.1.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.2 Contract Research Organizations
    • 12.2.1 Overview
    • 12.2.2 Contract Research Organizations: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.3 Business Process Outsourcing (BPO) Firms
    • 12.3.1 Overview
    • 12.3.2 Business Process Outsourcing (BPO) Firms: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.4 Others
    • 12.4.1 Overview
    • 12.4.2 Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

13. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Country Analysis

  • 13.1 Asia Pacific
    • 13.1.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.2 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.2.1 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.2.2 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.2.3 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.2.4 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.2.5 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.2.6 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.3 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.3.1 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.3.2 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.3.3 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.3.4 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.3.5 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.3.6 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.4 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.4.1 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.4.2 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.4.3 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.4.4 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.4.5 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.4.6 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.5 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.5.1 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.5.2 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.5.3 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.5.4 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.5.5 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.5.6 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.6 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.6.1 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.6.2 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.6.3 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.6.4 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.6.5 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.6.6 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.7 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.7.1 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.7.2 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.7.3 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.7.4 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.7.5 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.7.6 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User

14. Competitive Landscape

  • 14.1 Heat Map Analysis by Key Players
  • 14.2 Company Positioning and Concentration

15. Industry Landscape

  • 15.1 Overview
  • 15.2 Market Initiative
  • 15.3 Partnerships and Collaborations

16. Company Profiles

  • 16.1 ArisGlobal LLC
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Max Application
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Oracle Corp
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Veeva Systems Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 IQVIA Holdings Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 ICON Plc
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Cognizant Technology Solutions Corp
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Accenture Plc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Syneos Health Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Genpact Ltd.
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 AB Cube S.A.S.
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Laboratory Corp of America Holdings
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Parexel International Corp
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Qinecsa Solutions
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments
  • 16.15 Clinevo Technologies
    • 16.15.1 Key Facts
    • 16.15.2 Business Description
    • 16.15.3 Products and Services
    • 16.15.4 Financial Overview
    • 16.15.5 SWOT Analysis
    • 16.15.6 Key Developments

17. Appendix

  • 17.1 About Us
  • 17.2 List of Abbreviations

List Of Tables

  • Table 1. Asia Pacific Pharmacovigilance and Drug Safety Software Market Segmentation
  • Table 2. List of Vendors
  • Table 3. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Table 4. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Offering
  • Table 5. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Deployment
  • Table 6. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Enterprise Size
  • Table 7. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Form
  • Table 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Functionality
  • Table 9. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by End User
  • Table 10. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country
  • Table 11. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 12. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 13. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 14. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 15. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 16. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 17. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 18. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 19. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 20. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 21. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 22. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 23. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 24. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 25. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 26. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 27. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 28. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 29. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 30. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 31. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 32. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 33. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 34. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 35. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 36. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 37. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 38. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 39. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 40. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 41. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 42. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 43. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 44. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 45. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 46. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 47. List of Abbreviations

List Of Figures

  • Figure 1. Asia Pacific Pharmacovigilance and Drug Safety Software Market Segmentation - Country
  • Figure 2. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Offering (2023 and 2031)
  • Figure 6. Software: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 7. Services: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Deployment (2023 and 2031)
  • Figure 9. Cloud: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 10. On Premises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 11. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Enterprise Size (2023 and 2031)
  • Figure 12. Large Enterprises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 13. SMEs: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 14. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Form (2023 and 2031)
  • Figure 15. Standard: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 16. Customized: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 17. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Functionality (2023 and 2031)
  • Figure 18. Signal and Risk Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 19. Issue Tracking and Adverse Event Tracking: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 20. Case Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 21. Clinical Safety Management and Clinical Trial Safety: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 22. Quality and Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 23. Medical Writing: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 24. Audit Support and Training Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 25. Healthcare Analytics: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 26. Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 27. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by End User (2023 and 2031)
  • Figure 28. Pharmaceutical and Biotechnology Companies: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 29. Contract Research Organizations: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 30. Business Process Outsourcing (BPO) Firms: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 31. Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 32. Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 34. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 35. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 36. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 37. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 38. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 39. Heat Map Analysis by Key Players
  • Figure 40. Company Positioning and Concentration